Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.
about
Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expressionThe Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian CancerDecreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor geneMannose-6-phosphate receptors as a molecular indicator of maturation of epididymal sperm.RAS transformation requires CUX1-dependent repair of oxidative DNA damage.Cathepsin L targeting in cancer treatment.The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro.Cathepsin L inhibition by the small molecule KGP94 suppresses tumor microenvironment enhanced metastasis associated cell functions of prostate and breast cancer cellsReovirus-based therapy for cancer.Activated ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cells.Addition of exogenous protease facilitates reovirus infection in many restrictive cells.The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis.The biochemistry of cancer dissemination.Cathepsin L increases invasion and migration of B16 melanoma.Osteopontin is required for full expression of the transformed phenotype by the ras oncogene.Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels.Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain rea
P2860
Q24811240-4663D9BA-8AEA-482A-89DF-D7F0C6D9DD3AQ26776510-21B3BA4B-AD62-4E77-8FB5-F13E677CF20EQ30854542-407F30A5-6A67-4796-941E-9FEAF3A224CAQ34492202-22489D2D-1636-498F-A098-6D94C97D32C7Q35117739-2E91120B-FBCB-4C8D-8F85-D4E97D41C6A3Q36218199-CCBF6F9D-7245-4AB7-88C4-7DEC1A141930Q36612425-1035C017-2C7D-4914-985B-4A7B6A32A9B3Q37296811-90968A39-B3F1-4C3D-9A60-6F06991E1F68Q37519640-81A67F54-76D6-47DC-A463-4BA9B2874B0EQ38229052-CC74C3F5-0B0A-4DC0-ABDF-60C643C93B0BQ39684367-DD6D91A4-7FDA-4576-9831-1EECA7C7454BQ40401867-9B4ACB9D-D388-4D0B-B501-05CAEFF6CDB2Q41547351-F86CB570-DDCB-4447-AB2E-87ADDFC20B24Q42757004-748C0C0F-C4E2-4354-A747-5F6F86AC6252Q42799564-A14748D3-A6D8-4B27-8F00-D116BBD913DDQ46602647-EDEB4748-82B6-41FC-9C94-CAE231FF418AQ47685856-71D74390-DCBC-4BAD-8A2E-4CAD26539699
P2860
Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Increased expression of cathep ...... ras-transformed NIH 3T3 cells.
@en
type
label
Increased expression of cathep ...... ras-transformed NIH 3T3 cells.
@en
prefLabel
Increased expression of cathep ...... ras-transformed NIH 3T3 cells.
@en
P2093
P2860
P356
P1476
Increased expression of cathep ...... ras-transformed NIH 3T3 cells.
@en
P2093
P2860
P304
P356
10.1002/MC.2940050311
P577
1992-01-01T00:00:00Z